Global Trust Asset Management LLC bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 608 shares of the financial services provider’s stock, valued at approximately $50,000.
Other large investors also recently modified their holdings of the company. PFG Investments LLC grew its position in shares of MetLife by 8.9% in the 3rd quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock valued at $525,000 after purchasing an additional 520 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in MetLife in the third quarter valued at approximately $2,960,000. Segall Bryant & Hamill LLC acquired a new position in shares of MetLife in the third quarter valued at approximately $1,074,000. Meeder Asset Management Inc. increased its position in shares of MetLife by 48,101.4% during the third quarter. Meeder Asset Management Inc. now owns 106,043 shares of the financial services provider’s stock worth $8,746,000 after acquiring an additional 105,823 shares in the last quarter. Finally, Public Employees Retirement System of Ohio raised its holdings in shares of MetLife by 5.6% during the third quarter. Public Employees Retirement System of Ohio now owns 285,514 shares of the financial services provider’s stock worth $23,549,000 after acquiring an additional 15,251 shares during the period. 94.99% of the stock is currently owned by institutional investors.
MetLife Price Performance
Shares of MET opened at $85.78 on Thursday. The company’s 50-day moving average is $83.60 and its 200-day moving average is $79.78. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market capitalization of $59.39 billion, a PE ratio of 17.29, a PEG ratio of 0.66 and a beta of 1.07. MetLife, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $89.05.
MetLife Announces Dividend
Wall Street Analyst Weigh In
MET has been the subject of a number of research reports. JPMorgan Chase & Co. increased their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Wells Fargo & Company decreased their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a report on Tuesday, January 14th. Barclays boosted their target price on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. TD Cowen raised their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Finally, Jefferies Financial Group boosted their price objective on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $89.92.
Check Out Our Latest Analysis on MET
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What is the FTSE 100 index?
- Oracle Announces Game-Changing News for the AI Industry
- What is the Nikkei 225 index?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- How to Calculate Return on Investment (ROI)
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.